ProCAncer-I in the 44th International Engineering in Medicine and Biology Conference in Glasgow

Published on: July 5, 2022
Categories: News
We are looking forward to participating in the 44th IEEE International Engineering in Medicine and Biology Conference in Glasgow! The Initiative will organize a miniSymposium under the session on Biomedical Imaging and Image Processing, with the title: Trustworthy AI in Cancer Imaging Research! 

Cancer research has been central in the biomedical community, seeking earlier and safer cancer diagnosis and prognosis, as well as better and more personalized treatment decisions. AI is increasingly receiving attention as a major component leveraging cancer imaging and multi-omics data analysis, towards these goals.

A key factor to ensure the success and impact of AI in cancer research and secure the wider adoption in clinical practice is the aspect of trustworthiness. This entails a multifaceted strategy in all phases of an AI service development, spanning from AI design to training and validation and including –among others– human oversight, technical robustness, data governance, transparency, fairness, and auditability. AI trustworthiness is currently moving from the definition of its theoretical framework capturing all trustworthiness perspectives to guidelines and best practices for its practical implementation. It is also evolving to incorporate the particularities of the cancer research areas and the needs of the w hole user spectrum. Incorporating explainability/interpretability in AI is an emerging field that is receiving lately much attention, while XAI validation is still an open issue that also involves several human aspects. As regards the much-discussed AI fairness, recent initiatives attempt to generate a framework based on best practices. Keeping in mind these multiple and diverse challenges and opportunities in the field of cancer research, the aim of this mini-symposium is to address the important questions: “How to design AI that is trustworthy”, and “How to validate AI trustworthiness” in the scope of AI for cancer imaging.

Speaker will be:

Ioanna Chouvarda, Aristotle University of Thessaloniki, Greece Karim Lekadir, University of Barcelona, Spain
Fuensanta Bellvis Bataller, Quibim, Spain Sara Colantonio, CNR, Italy
Haridimos Kondylakis, ICS-FORTH, Greece
Alexandra Kosvyra, Aristotle University of Thessaloniki, Greece
João Santinha, Champalimaud Foundation, Portugal

For more information about the Conference: https://embc.embs.org/2022

Highlights

European Cancer Imaging Initiative launch event

European Cancer Imaging Initiative launch event

The Commission is organising a hybrid event on 23 January 2023 in Brussels to mark the launch of the Cancer Imaging Initiative, one of the Flagship Initiatives of the Europe’s Beating Cancer Plan. This 2.5-hour event will present the policy background and the Cancer...

ProCAncer-I at the RSNA 2022 in Chicago

ProCAncer-I at the RSNA 2022 in Chicago

Our Scientific Manager, Dr Nickolas Papanikolaou was at the 108th Scientific Assembly and Annual meeting (Chicago 27-30/11/2022). The panel discussion included Dr Mona Flores, Global Head of Medical AI at NVIDIA, and Dr Nikos Papanikolaou, Computational Clinical...

Stay in touch!